Naunyn-Schmiedeberg's archives of pharmacology
Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation.
Xingdong Cheng, Dengyan Zhu, Haizhou Guo, Tianliang Zheng, Bin Wu, Yinliang Sheng, Feng Li, Guangcheng Sun, Song Zhao, Li Ke, Zhuoyu Gu
Published: 202610.1007/s00210-026-05031-3
Abstract
Myocardial ischemia/reperfusion injury (MI/RI) is a complex state involving numerous inflammatory mediators, which significantly worsens the outcomes of patients with cardiovascular diseases. However, no standardized treatment plan for MI/RI prevails…
Preview only. Read the full abstract at the source